Jazz preps first solid tumor launch with Zepzelca's small cell lung cancer nod

Jazz Pharmaceuticals is prepping its first solid tumor cancer treatment for launch in early July, focusing on physician awareness and education. That's in part because Zepzelca is the first drug approved for previously treated small cell lung cancer in more than 20 years.